{
  "docId": "019dd923-622c-750b-8b98-0c85e40ec39b",
  "docSlug": "9b248b07037e",
  "documentTitle": "CareDx, Inc. (CDNA)",
  "authorId": "53_Kerrisdale_Capital",
  "authorName": "Kerrisdale Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-07-01 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 1,
  "pageCount": 29,
  "prevPage": null,
  "nextPage": 2,
  "slideType": "executive_summary",
  "function": "diagnose_problem",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "This is a classic activist short-seller research note cover page.",
  "elementsJson": [
    "paragraph",
    "callout_box"
  ],
  "metadataConfidence": 1,
  "imagePath": "https://imgproxy.kitesheet.com/KScwSuJmXVpigTPGocffAVk4YpgKs2ckmcetH9nqyAo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YjI0OGIwNzAzN2UvcDAwMS5wbmc",
  "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/1",
  "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-1",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "CareDx, reliant on a single ineffective test, will soon confront its own terminal diagnosis.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-203e-77ad-a69c-2f0b14bc046c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.76,
        "x": 0.12,
        "y": 0.895
      },
      "kind": "disclaimer",
      "text": "Disclaimer: As of the publication date of this report, Kerrisdale Capital Management, LLC and its affiliates (collectively, “Kerrisdale”), have short positions in and own option interests on the stock of CareDx, Inc.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "91b6e147-1073-45d7-9e86-4cc04c603a6d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.76,
        "x": 0.12,
        "y": 0.165
      },
      "kind": "paragraph",
      "text": "We are short shares of CareDx, a $1.7bn diagnostics company whose share price has increased by 30x over just the last two years and now trades at over 18x sales.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a80183af-45ef-4e04-bb07-2c4ed7eb1875",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.76,
        "x": 0.12,
        "y": 0.485
      },
      "kind": "paragraph",
      "text": "We calculate that CareDx has faced a quarterly attrition rate on AlloSure’s surveillance patient population of 20-30%.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a942cd88-1eec-4107-8971-8e484ac4e8f4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "To hear CareDx tell it, AlloSure is the long sought-after silver bullet for rejection diagnosis, with the potential to “revolutionize the treatment of kidney transplant patients.” It can help physicians “detect rejection of a donated organ earlier and more accurately” than traditional blood-based measures of kidney function and “reduce the use of invasive biopsies.” — CareDx (marketing materials)",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-203e-77ad-a69c-30ac962ec670",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.24,
        "x": 0.38,
        "y": 0.1
      },
      "kind": "title",
      "text": "CareDx, Inc. (CDNA)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab12b0d5-168e-4c99-8ca3-3d92c259c05e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.52,
        "x": 0.24,
        "y": 0.135
      },
      "kind": "title",
      "text": "Pivotal Kidney Transplant Test Headed for Rejection",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bbfad746-b63a-4223-b8ca-4273d55f9960",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "38ddf4d8-ca8c-4b0e-8829-8e17d1b1c450",
      "evidence": "The slide frames CareDx as a company with a failing product and misleading narrative.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": "https://imgproxy.kitesheet.com/zEqOgZL5o5f243073YlVJ5DsGDFNJ1jLVsVjH4OPFKU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YjI0OGIwNzAzN2UvcDAwMS5qcGc",
  "thumbSrc": "https://imgproxy.kitesheet.com/AHbd27mRDAiQG-JYGHivla8xCwq3hyJYcp5Z5cpBsfI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YjI0OGIwNzAzN2UvcDAwMS5wbmc",
  "thumbSrcAlt": "https://imgproxy.kitesheet.com/d5N8t9FZbKtoqdpdiB4koNTCGuyZMkoT_W1UQStTuiw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YjI0OGIwNzAzN2UvcDAwMS5qcGc"
}